GIPR
Basic information
Region (hg38): 19:45668221-45683722
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GIPR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 0 | 0 |
Variants in GIPR
This is a list of pathogenic ClinVar variants found in the GIPR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-45669542-C-G | not specified | Uncertain significance (Aug 09, 2021) | ||
19-45669554-C-G | not specified | Uncertain significance (Sep 25, 2023) | ||
19-45669567-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
19-45669569-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
19-45669588-C-G | not specified | Uncertain significance (Dec 27, 2022) | ||
19-45670654-C-A | not specified | Uncertain significance (Oct 05, 2021) | ||
19-45670663-A-G | not specified | Uncertain significance (Sep 15, 2021) | ||
19-45670669-A-C | not specified | Uncertain significance (Nov 28, 2023) | ||
19-45671309-A-T | not specified | Uncertain significance (Nov 07, 2023) | ||
19-45671665-A-C | Benign (Jul 01, 2024) | |||
19-45672901-C-G | not specified | Uncertain significance (Nov 21, 2022) | ||
19-45674076-C-A | not specified | Uncertain significance (Dec 13, 2022) | ||
19-45674108-T-C | not specified | Uncertain significance (Nov 01, 2021) | ||
19-45677097-T-A | not specified | Uncertain significance (Oct 03, 2022) | ||
19-45677711-T-C | not specified | Uncertain significance (Jul 26, 2021) | ||
19-45677753-C-T | not specified | Uncertain significance (Apr 25, 2022) | ||
19-45677766-T-G | not specified | Uncertain significance (Jan 31, 2022) | ||
19-45677768-A-G | not specified | Uncertain significance (Sep 29, 2022) | ||
19-45678141-T-C | not specified | Uncertain significance (Apr 25, 2022) | ||
19-45678182-C-A | not specified | Uncertain significance (May 14, 2024) | ||
19-45681744-C-A | not specified | Uncertain significance (Apr 25, 2023) | ||
19-45681765-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
19-45681777-A-G | not specified | Uncertain significance (May 04, 2022) | ||
19-45681778-G-T | not specified | Uncertain significance (May 09, 2024) | ||
19-45681873-T-A | not specified | Uncertain significance (Jan 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GIPR | protein_coding | protein_coding | ENST00000590918 | 13 | 15481 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.97e-29 | 0.00000158 | 125471 | 0 | 277 | 125748 | 0.00110 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.960 | 299 | 256 | 1.17 | 0.0000137 | 2919 |
Missense in Polyphen | 123 | 89.938 | 1.3676 | 1130 | ||
Synonymous | 0.769 | 102 | 112 | 0.908 | 0.00000615 | 974 |
Loss of Function | -1.73 | 38 | 28.1 | 1.35 | 0.00000146 | 276 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00135 | 0.00134 |
Ashkenazi Jewish | 0.000603 | 0.000595 |
East Asian | 0.00809 | 0.00797 |
Finnish | 0.00111 | 0.00111 |
European (Non-Finnish) | 0.000417 | 0.000413 |
Middle Eastern | 0.00809 | 0.00797 |
South Asian | 0.000622 | 0.000621 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: This is a receptor for GIP. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.;
- Pathway
- cAMP signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Class B Secretin-like;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Glucagon-type ligand receptors;Class B/2 (Secretin family receptors);GPCR ligand binding;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.167
Intolerance Scores
- loftool
- 0.964
- rvis_EVS
- 0.69
- rvis_percentile_EVS
- 85.18
Haploinsufficiency Scores
- pHI
- 0.418
- hipred
- N
- hipred_score
- 0.238
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.601
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gipr
- Phenotype
- endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- desensitization of G protein-coupled receptor signaling pathway;generation of precursor metabolites and energy;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;activation of adenylate cyclase activity;positive regulation of cytosolic calcium ion concentration;response to nutrient;response to glucose;endocrine pancreas development;positive regulation of insulin secretion;gastric inhibitory peptide signaling pathway;positive regulation of cAMP-mediated signaling;response to axon injury;regulation of insulin secretion;response to calcium ion;response to fatty acid
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- transmembrane signaling receptor activity;protein binding;G protein-coupled peptide receptor activity;gastric inhibitory peptide receptor activity;peptide hormone binding